Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Molecular Basis of KELnull Phenotype in Brazilians

Full text
Author(s):
Boturao-Neto, Edmir [1] ; Yamamoto, Mihoko [1] ; Chiba, Akemi Kuroda [1] ; Sugano Kimura, Elisa Yuriko [1] ; Valgueiro Costa de Oliveira, Maria do Carmo [2] ; do Monte Barretto, Claudia Lumack [2] ; Alves Nunes, Mercia Maria [2] ; Lopes Albuquerque, Sergio Roberto [3] ; de Deus Santos, Marcos Daniel [4] ; Bordin, Jose Orlando [1]
Total Authors: 10
Affiliation:
[1] Univ Fed Sao Paulo, Hematol & Transfus Med Dept, BR-04023092 Sao Paulo, SP - Brazil
[2] Fundacao HEMOPE, Hemotherapy Dept, Recife, PE - Brazil
[3] Fundacao Hosp Hematol & Hemoterapia Estado Amazon, Immunohematol Dept, Manaus, AM - Brazil
[4] Univ Fed Espirito Santo, Dept Internal Med, Vila Velha, ES - Brazil
Total Affiliations: 4
Document type: Journal article
Source: TRANSFUSION MEDICINE AND HEMOTHERAPY; v. 42, n. 1, p. 52-58, 2015.
Web of Science Citations: 2
Abstract

Background: KELnull (K-0) persons can produce clinically significant anti-KEL5 antibody after transfusion and/or pregnancy, requiring K-0 blood transfusion when indicated. 37 K-0 alleles have been reported in studies over different populations, but none in Amerindian-Caucasian descendants from South America. The aim of this study was to identify the molecular basis of K-0 phenotype in Brazilians. Methods: We investigated three K-0 samples from different Brazilian blood banks (Recife, Manaus, and Vila Velha) in women with anti-KEL5. KEL antigen typing was performed by serologic techniques, and the K-0 status was confirmed by flow cytometry. PCR-RFLP and DNA sequencing of the KEL coding and exon-intron regions were also performed. Results: RBCs of the 3 patients were phenotyped as KEL:-1,-2,-3,-4,-7. The 3 patients had the same KEL{*}02/02 genotype and were negative for KEL{*}02.03 and KEL{*}02.06 alleles. The Recife K-0 patient was homozygous for IVS16 + 1g>a mutation (KEL{*}02N.31 allele). The flow cytometry with anti-KEL1, anti-KEL2, anti-KEL3, anti-KEL4, and anti-CD238 confirmed the K-0 phenotype. In addition, we found the c.1042C>T mutation (KEL{*}02N.04 allele) in both the Manaus K-0 and the Vila Velha K-0 patients. Conclusion: This report represents the first study of K-0 molecular basis performed in Amerindian-Caucasian descendants from South America. (AU)

FAPESP's process: 05/55237-9 - Clinical and molecular aspects of antigens and antibodies of blood cells
Grantee:Jose Orlando Bordin
Support Opportunities: Research Projects - Thematic Grants